Harvard Bioscience Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Harvard Bioscience (HBIO) Misses Q4 EPS by 3c
April 30, 2015 9:33 AM EDTHarvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.02, $0.03 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $25.8 million versus the consensus estimate of $27.15 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
... More